Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) clinical trial (NCT03561701). Contact the study team or your healthcare provider for specific answers.

Question 2

How does oteseconazole compare to other treatments I have tried?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) clinical trial (NCT03561701). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from oteseconazole?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) clinical trial (NCT03561701). Contact the study team or your healthcare provider for specific answers.

Question 4

What will my participation involve in terms of visits and medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) clinical trial (NCT03561701). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) clinical trial (NCT03561701). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience a yeast infection while in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) clinical trial (NCT03561701). Contact the study team or your healthcare provider for specific answers.

What this study is about